A Study of First-line Maintenance Erlotinib Versus Erlotinib at Disease Progression in Participants With Advanced Non-Small Cell Lung Cancer (NSCLC) Who Have Not Progressed Following Platinum-Based Chemotherapy

Clinical trial NCT01328951 · COMPLETED

Trial details

NCT number: NCT01328951
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Non-Squamous Non-Small Cell Lung Cancer

Start date: 2011-09-01
Primary completion: 2015-12-01
Enrollment: 643

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.